Your browser doesn't support javascript.
loading
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.
Dooley, Kelly E; Hanna, Debra; Mave, Vidya; Eisenach, Kathleen; Savic, Radojka M.
Afiliação
  • Dooley KE; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Hanna D; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
  • Mave V; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Eisenach K; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Savic RM; TB or NOT TB Consulting, LLC, Little Rock, Arkansas, United States of America.
PLoS Med ; 16(7): e1002842, 2019 07.
Article em En | MEDLINE | ID: mdl-31276490
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacologia Clínica / Tuberculose / Pesquisa Translacional Biomédica / Desenvolvimento de Medicamentos / Microbiologia / Mycobacterium tuberculosis / Antituberculosos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacologia Clínica / Tuberculose / Pesquisa Translacional Biomédica / Desenvolvimento de Medicamentos / Microbiologia / Mycobacterium tuberculosis / Antituberculosos Idioma: En Ano de publicação: 2019 Tipo de documento: Article